These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27125599)

  • 1. The IRIS (Insulin Resistance Intervention after Stroke) trial: A new perspective on pioglitazone.
    Inzucchi SE; Furie KL
    J Diabetes; 2016 Sep; 8(5):607-9. PubMed ID: 27125599
    [No Abstract]   [Full Text] [Related]  

  • 2. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
    N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Hu K; Xu W; Williams Z
    N Engl J Med; 2016 Aug; 375(7):703-4. PubMed ID: 27532848
    [No Abstract]   [Full Text] [Related]  

  • 4. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Doehner W; Anker SD
    N Engl J Med; 2016 Aug; 375(7):703. PubMed ID: 27532847
    [No Abstract]   [Full Text] [Related]  

  • 5. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Bursztyn M
    N Engl J Med; 2016 Aug; 375(7):702-3. PubMed ID: 27532846
    [No Abstract]   [Full Text] [Related]  

  • 6. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Viscoli CM; Kernan WN; Young LH
    N Engl J Med; 2016 Aug; 375(7):704. PubMed ID: 27532845
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin Resistance and a Long, Strange Trip.
    Semenkovich CF
    N Engl J Med; 2016 Apr; 374(14):1378-9. PubMed ID: 26886417
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.
    Kernan WN; Viscoli CM; Dearborn JL; Kent DM; Conwit R; Fayad P; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Stuart A; Young LH;
    JAMA Neurol; 2017 Nov; 74(11):1319-1327. PubMed ID: 28975241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.
    Young LH; Viscoli CM; Curtis JP; Inzucchi SE; Schwartz GG; Lovejoy AM; Furie KL; Gorman MJ; Conwit R; Abbott JD; Jacoby DL; Kolansky DM; Pfau SE; Ling FS; Kernan WN;
    Circulation; 2017 May; 135(20):1882-1893. PubMed ID: 28246237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.
    Inzucchi SE; Viscoli CM; Young LH; Furie KL; Gorman M; Lovejoy AM; Dagogo-Jack S; Ismail-Beigi F; Korytkowski MT; Pratley RE; Schwartz GG; Kernan WN;
    Diabetes Care; 2016 Oct; 39(10):1684-92. PubMed ID: 27465265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
    Spence JD; Viscoli C; Kernan WN; Young LH; Furie K; DeFronzo R; Abdul-Ghani M; Dandona P; Inzucchi SE
    Diabetes Obes Metab; 2022 Jun; 24(6):1150-1158. PubMed ID: 35253334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial.
    Furie KL; Viscoli CM; Gorman M; Ford GA; Young LH; Inzucchi SE; Guarino PD; Lovejoy AM; Conwit R; Tanne D; Kernan WN;
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):21-27. PubMed ID: 28939682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
    Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
    Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
    Yaghi S; Furie KL; Viscoli CM; Kamel H; Gorman M; Dearborn J; Young LH; Inzucchi SE; Lovejoy AM; Kasner SE; Conwit R; Kernan WN;
    Circulation; 2018 Jan; 137(5):455-463. PubMed ID: 29084736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke.
    Kernan WN; Inzucchi SE; Viscoli CM; Brass LM; Bravata DM; Shulman GI; McVeety JC; Horwitz RI
    Stroke; 2003 Jun; 34(6):1431-6. PubMed ID: 12730556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to study drug in a stroke prevention trial"?>.
    Kiran A; Viscoli CM; Furie KL; Gorman M; Kernan WN
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105048. PubMed ID: 32912514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.
    Viscoli CM; Inzucchi SE; Young LH; Insogna KL; Conwit R; Furie KL; Gorman M; Kelly MA; Lovejoy AM; Kernan WN;
    J Clin Endocrinol Metab; 2017 Mar; 102(3):914-922. PubMed ID: 27935736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.
    Viscoli CM; Brass LM; Carolei A; Conwit R; Ford GA; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Lovejoy AM; Parsons MW; Peduzzi PN; Ringleb PA; Schwartz GG; Spence JD; Tanne D; Young LH; Kernan WN;
    Am Heart J; 2014 Dec; 168(6):823-9.e6. PubMed ID: 25458644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin Resistance Intervention After Stroke Trial of Pioglitazone: Is This Perhaps the End of the Beginning?
    Ntaios G; Kent TA
    Stroke; 2016 Jul; 47(7):1962-4. PubMed ID: 27222525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.